Breakthrough Injectable Biomaterial Repairs Damaged Tissue via Bloodstream

Scientists at the University of California, San Diego, have developed a groundbreaking injectable biomaterial capable of repairing damaged tissue from within the body by traveling through the bloodstream. This innovative therapy, detailed in Nature Biomedical Engineering, reduces inflammation and accelerates healing without requiring direct injection into affected organs. In animal studies, the material successfully treated heart attack damage in both rodents and large animals, showing significant promise for conditions such as traumatic brain injury and pulmonary hypertension. Unlike previous hydrogel treatments that necessitated invasive catheter-based delivery directly into heart muscle, this new approach can be administered intravenously or during standard procedures like angioplasty. This allows for quicker, more even distribution and immediate application post-injury, addressing a critical limitation of earlier methods. The research team, led by Professor Karen Christman, aims to initiate human clinical trials to test safety and effectiveness, potentially revolutionizing regenerative medicine for cardiovascular and other inflammation-driven diseases.